-
Je něco špatně v tomto záznamu ?
Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice
E Machova, J Jakubik, P Michal, M Oksman, H Iivonen, H Tanila, V Dolezal
Jazyk angličtina Země Spojené státy americké
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- acetylcholinesterasa metabolismus MeSH
- amyloidový prekurzorový protein beta metabolismus MeSH
- analýza rozptylu MeSH
- financování organizované MeSH
- geneticky modifikovaná zvířata MeSH
- guanosin 5'-O-(3-thiotrifosfát) metabolismus MeSH
- lidé MeSH
- mutace MeSH
- myši MeSH
- N-methylskopolamin MeSH
- nervový přenos genetika MeSH
- piperidiny farmakokinetika metabolismus MeSH
- presenilin-1 genetika MeSH
- receptory muskarinové metabolismus MeSH
- vazba proteinů účinky léků MeSH
- věkové faktory MeSH
- vezikulární transportní proteiny acetylcholinu metabolismus MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
We assessed the integrity of cholinergic neurotransmission in parietal cortex of young adult (7 months) and aged (17 months) transgenic APPswe/PS1dE9 female mice compared to littermate controls. Choline acetyltransferase and acetylcholinesterase activity declined age-dependently in both genotypes, whereas both age- and genotype-dependent decline was found in butyrylcholinesterase activity, vesicular acetylcholine transporter density, muscarinic receptors and carbachol stimulated binding of GTP gamma S in membranes as a functional indicator of muscarinic receptor coupling to G-proteins. Notably, vesicular acetylcholine transporter levels and muscarinic receptor-G-protein coupling were impaired in transgenic mice already at the age of 7 months compared to wild type littermates. Thus, brain amyloid accumulation in this mouse model is accompanied by a serious deterioration of muscarinic transmission already before the mice manifest significant cognitive deficits.
Department of Neurochemistry Institute of Physiology CAS Videnska 1083 14220 Prague 4 Czech Republic
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10026374
- 003
- CZ-PrNML
- 005
- 20200313100745.0
- 008
- 101018s2008 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Machová, Eva. $7 _AN045395
- 245 10
- $a Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice / $c E Machova, J Jakubik, P Michal, M Oksman, H Iivonen, H Tanila, V Dolezal
- 314 __
- $a Department of Neurochemistry, Institute of Physiology CAS, Videnska 1083, 14220 Prague 4, Czech Republic.
- 520 9_
- $a We assessed the integrity of cholinergic neurotransmission in parietal cortex of young adult (7 months) and aged (17 months) transgenic APPswe/PS1dE9 female mice compared to littermate controls. Choline acetyltransferase and acetylcholinesterase activity declined age-dependently in both genotypes, whereas both age- and genotype-dependent decline was found in butyrylcholinesterase activity, vesicular acetylcholine transporter density, muscarinic receptors and carbachol stimulated binding of GTP gamma S in membranes as a functional indicator of muscarinic receptor coupling to G-proteins. Notably, vesicular acetylcholine transporter levels and muscarinic receptor-G-protein coupling were impaired in transgenic mice already at the age of 7 months compared to wild type littermates. Thus, brain amyloid accumulation in this mouse model is accompanied by a serious deterioration of muscarinic transmission already before the mice manifest significant cognitive deficits.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a amyloidový prekurzorový protein beta $7 D016564
- 650 _2
- $a amyloidový prekurzorový protein beta $x metabolismus $7 D016564
- 650 _2
- $a analýza rozptylu $7 D000704
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a geneticky modifikovaná zvířata $7 D030801
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a guanosin 5'-O-(3-thiotrifosfát) $x metabolismus $7 D016244
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a N-methylskopolamin $7 D019832
- 650 _2
- $a piperidiny $x farmakokinetika $x metabolismus $7 D010880
- 650 _2
- $a presenilin-1 $x genetika $7 D053764
- 650 _2
- $a vazba proteinů $x účinky léků $7 D011485
- 650 _2
- $a receptory muskarinové $x metabolismus $7 D011976
- 650 _2
- $a nervový přenos $x genetika $7 D009435
- 650 _2
- $a vezikulární transportní proteiny acetylcholinu $x metabolismus $7 D050494
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Jakubík, Jan. $7 xx0281420
- 700 1_
- $a Michal, Pavel. $7 _BN002852
- 700 1_
- $a Oksman, M. $7 _BN002855
- 700 1_
- $a Iivonen, H
- 700 1_
- $a Tanila, H
- 700 1_
- $a Doležal, Vladimír, $d 1952 červen 12.- $7 nlk19990073099
- 773 0_
- $w MED00006329 $t Neurobiology of aging $g Roč. 29, č. 3 (2008), s. 368-378 $x 0197-4580
- 910 __
- $a ABA008 $b x $y 7 $z 0
- 990 __
- $a 20110112132213 $b ABA008
- 991 __
- $a 20200313101205 $b ABA008
- 999 __
- $a ok $b bmc $g 801479 $s 666226
- BAS __
- $a 3
- BMC __
- $a 2008 $b 29 $c 3 $d 368-378 $m Neurobiology of aging $n Neurobiol Aging $x MED00006329
- LZP __
- $a 2010-B/mk